118 related articles for article (PubMed ID: 12005158)
21. [Effect of danshen injection on expression of platelet membrane glycoproteins in patients with type II diabetes mellitus].
Zhang M; Li X; Jiu G; Liu Y
Zhong Yao Cai; 2003 Oct; 26(10):738-40. PubMed ID: 14768394
[TBL] [Abstract][Full Text] [Related]
22. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies.
Escolar G; White JG
Thromb Haemost; 2000 Mar; 83(3):371-86. PubMed ID: 10744140
[No Abstract] [Full Text] [Related]
23. Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease.
Malinin AI; Atar D; Callahan KP; McKenzie ME; Serebruany VL
Eur J Pharmacol; 2003 Feb; 462(1-3):139-43. PubMed ID: 12591106
[TBL] [Abstract][Full Text] [Related]
24. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
[TBL] [Abstract][Full Text] [Related]
25. [Expression patterns of platelet membrane glycoprotein in healthy adults].
Huang F; Liu R; Liu L
Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):465-7. PubMed ID: 11721409
[TBL] [Abstract][Full Text] [Related]
26. Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber.
Bode AP; Read MS; Reddick RL
J Lab Clin Med; 1999 Feb; 133(2):200-11. PubMed ID: 9989772
[TBL] [Abstract][Full Text] [Related]
27. Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
Serebruany V; Malinin A; Pokov A; Arora U; Atar D; Angiolillo D
Thromb Res; 2007; 119(2):175-81. PubMed ID: 16546241
[TBL] [Abstract][Full Text] [Related]
28. Dietary coenzyme Q10 supplementation alters platelet size and inhibits human vitronectin (CD51/CD61) receptor expression.
Serebruany VL; Ordonez JV; Herzog WR; Rohde M; Mortensen SA; Folkers K; Gurbel PA
J Cardiovasc Pharmacol; 1997 Jan; 29(1):16-22. PubMed ID: 9007665
[TBL] [Abstract][Full Text] [Related]
29. Reversible exposure of human platelet fibrinogen receptors by antiplatelet tetraspanin monoclonal antibodies via induction of a conformational change in membrane glycoprotein IIb/IIIa complex.
Wu H; Peng L; Li J; Wu W; Hou Q; Liu H; Wang M
Thromb Res; 1999 Sep; 95(5):245-53. PubMed ID: 10515289
[TBL] [Abstract][Full Text] [Related]
30. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils.
Taylor ML; Ilton MK; Misso NL; Watkins DN; Hung J; Thompson PJ
Br J Clin Pharmacol; 1998 Aug; 46(2):139-45. PubMed ID: 9723822
[TBL] [Abstract][Full Text] [Related]
31. In Vivo and protease-activated receptor-1-mediated platelet activation in patients presenting for cardiac catheterization.
Gremmel T; Michelson AD; Frelinger AL
Platelets; 2016 Jun; 27(4):308-16. PubMed ID: 26556638
[TBL] [Abstract][Full Text] [Related]
32. Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro.
Inoue T; Sohma R; Morooka S
Thromb Res; 1999 Feb; 93(3):137-43. PubMed ID: 10030830
[TBL] [Abstract][Full Text] [Related]
33. The in vitro effects of niacin on platelet biomarkers in human volunteers.
Serebruany V; Malinin A; Aradi D; Kuliczkowski W; Norgard NB; Boden WE
Thromb Haemost; 2010 Aug; 104(2):311-7. PubMed ID: 20539903
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric analysis of coronary stent-induced alterations of platelet antigens in an in vitro model.
Gutensohn K; Beythien C; Bau J; Meinertz T; Kuehnl P
Thromb Res; 1997 Apr; 86(1):49-56. PubMed ID: 9172286
[TBL] [Abstract][Full Text] [Related]
35. [Influence of a bolus injection of thiopental and propofol on the expression density of P-selectin and fibrinogen receptors on the surface of human platelets ex vivo].
Scheinichen D; Bornscheuer A; Jaeger K; Mahr KH; Koksch M; Ruschulte H; Heine J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Jul; 37(7):403-8. PubMed ID: 12101513
[TBL] [Abstract][Full Text] [Related]
36. Platelet-monocyte complex formation: effect of blocking PSGL-1 alone, and in combination with alphaIIbbeta3 and alphaMbeta2, in coronary stenting.
Fernandes LS; Conde ID; Wayne Smith C; Kansas GS; Snapp KR; Bennet N; Ballantyne C; McIntire LV; O'Brian Smith E; Klem JA; Mathew S; Frangogiannis N; Turner NA; Maresh KJ; Kleiman NS
Thromb Res; 2003; 111(3):171-7. PubMed ID: 14678816
[TBL] [Abstract][Full Text] [Related]
37. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
[TBL] [Abstract][Full Text] [Related]
38. In vitro measurement of platelet glycoprotein IIb/IIIa receptor blockade by abciximab: interindividual variation and increased platelet secretion.
Rossi F; Rossi E; Pareti FI; Colli S; Tremoli E; Gallo L
Haematologica; 2001 Feb; 86(2):192-8. PubMed ID: 11224490
[TBL] [Abstract][Full Text] [Related]
39. Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery disease.
Lindemann S; Klingel B; Fisch A; Meyer J; Darius H
Thromb Res; 1999 Jan; 93(2):51-9. PubMed ID: 9950258
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune thrombocytopenic purpura (AITP) and acquired thrombasthenia due to autoantibodies to GP IIb-IIIa in a patient with an unusual platelet membrane glycoprotein composition.
Macchi L; Nurden P; Marit G; Bihour C; Clofent-Sanchez G; Combrié R; Nurden AT
Am J Hematol; 1998 Feb; 57(2):164-75. PubMed ID: 9462551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
